Cargando…

CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane

CFTR is a membrane protein that functions as an ion channel. Mutations that disrupt its biosynthesis, trafficking or function cause cystic fibrosis (CF). Here, we present a novel in vitro model system prepared using CRISPR/Cas9 genome editing with endogenously expressed WT-CFTR tagged with a HiBiT p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ondra, Martin, Lenart, Lukas, Centorame, Amanda, Dumut, Daciana C, He, Alexander, Zaidi, Syeda Sadaf Zehra, Hanrahan, John W, De Sanctis, Juan Bautista, Radzioch, Danuta, Hajduch, Marian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Life Science Alliance LLC 2023
Materias:	Methods
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622324/ https://www.ncbi.nlm.nih.gov/pubmed/37918963 http://dx.doi.org/10.26508/lsa.202302045

Ejemplares similares

Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease
por: Centorame, Amanda, et al.
Publicado: (2022)

Functionally Relevant Differences in Plasma Fatty Acid Composition and Expression of Cytotoxic and Inhibitory NK Cell Receptors between Healthy Young and Healthy Elder Adults
por: De Sanctis, Juan Bautista, et al.
Publicado: (2020)

One-Step Synthesis of Nanoliposomal Copper Diethyldithiocarbamate and Its Assessment for Cancer Therapy
por: Paun, Radu A., et al.
Publicado: (2022)

Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages
por: Zhang, Shuzhong, et al.
Publicado: (2020)

Lack of CFTR in Skeletal Muscle Predisposes to Muscle Wasting and Diaphragm Muscle Pump Failure in Cystic Fibrosis Mice
por: Divangahi, Maziar, et al.
Publicado: (2009)

Editorial: Quo Vadis Lipid Mediators – Lipid Mediators Implication in Inflammation and Chronic Inflammatory Diseases
por: Radzioch, Danuta, et al.
Publicado: (2021)

CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells
por: Veltman, Mieke, et al.
Publicado: (2021)

Clinical Relevance of KRAS in Human Cancers
por: Jančík, Sylwia, et al.
Publicado: (2010)

Rescue of Mutant CFTR Trafficking Defect by the Investigational Compound MCG1516A
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2022)

Phenotypes of CF rabbits generated by CRISPR/Cas9-mediated disruption of the CFTR gene
por: Xu, Jie, et al.
Publicado: (2021)

Compounds that correct F508del-CFTR trafficking can also correct other protein trafficking diseases: an in vitro study using cell lines
por: Sampson, Heidi M, et al.
Publicado: (2013)

Decreasing Poly(ADP-Ribose) Polymerase Activity Restores ΔF508 CFTR Trafficking
por: Anjos, Suzana M., et al.
Publicado: (2012)

COMMD1-Mediated Ubiquitination Regulates CFTR Trafficking
por: Drévillon, Loïc, et al.
Publicado: (2011)

Regulatory Crosstalk by Protein Kinases on CFTR Trafficking and Activity
por: Farinha, Carlos M., et al.
Publicado: (2016)

Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing
por: Walker, Amy J., et al.
Publicado: (2023)

Characterization of two rat models of cystic fibrosis—KO and F508del CFTR—Generated by Crispr‐Cas9
por: Dreano, Elise, et al.
Publicado: (2019)

THU407 CRISPR/Cas9-based Knockout Of CFTR Alters Mechano-sensitivity And Proteomic Profile In An Osteocyte Model
por: Du, Wanting, et al.
Publicado: (2023)

Ceramide in Cystic Fibrosis: A Potential New Target for Therapeutic Intervention
por: Wojewodka, Gabriella, et al.
Publicado: (2011)

Network Biology Identifies Novel Regulators of CFTR Trafficking and Membrane Stability
por: Loureiro, Cláudia Almeida, et al.
Publicado: (2019)

Cigarette Smoke Exposure Induces Retrograde Trafficking of CFTR to the Endoplasmic Reticulum
por: Marklew, Abigail J., et al.
Publicado: (2019)

Phenotyping of Rare CFTR Mutations Reveals Distinct Trafficking and Functional Defects
por: Ensinck, Marjolein, et al.
Publicado: (2020)

CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates
por: Shishido, Hideki, et al.
Publicado: (2020)

Diversified local CRISPR-Cas immunity to viruses of Sulfolobus islandicus
por: Pauly, Matthew D., et al.
Publicado: (2019)

CFTR founder mutation causes protein trafficking defects in Chinese patients with cystic fibrosis
por: Leung, Gordon K. C., et al.
Publicado: (2016)

Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs
por: Kudlova, Natalie, et al.
Publicado: (2022)

Precise CRISPR-Cas9-mediated mutation of a membrane trafficking domain in the Drosophila vesicular monoamine transporter gene
por: Asuncion, James D., et al.
Publicado: (2023)

Development of Automated Patch Clamp Technique to Investigate CFTR Chloride Channel Function
por: Billet, Arnaud, et al.
Publicado: (2017)

CRISPR/Cas9-Mediated Immunity to Geminiviruses: Differential Interference and Evasion
por: Ali, Zahir, et al.
Publicado: (2016)

Engineering Plant Immunity: Using CRISPR/Cas9 to Generate Virus Resistance
por: Zaidi, Syed Shan-e-Ali, et al.
Publicado: (2016)

Constrained Bithiazoles: Small Molecule Correctors of Defective ΔF508–CFTR Protein Trafficking
por: Coffman, Keith C., et al.
Publicado: (2014)

Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment
por: Capurro, Valeria, et al.
Publicado: (2021)

Rescue of Rare CFTR Trafficking Mutants Highlights a Structural Location-Dependent Pattern for Correction
por: Zacarias, Sónia, et al.
Publicado: (2023)

Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014)

Corrigendum: CRISPR/Cas9-Mediated Immunity to Geminiviruses: Differential Interference and Evasion
por: Ali, Zahir, et al.
Publicado: (2016)

Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids
por: Geurts, Maarten H, et al.
Publicado: (2021)

Agonists that stimulate secretion promote the recruitment of CFTR into membrane lipid microdomains
por: Abu-Arish, Asmahan, et al.
Publicado: (2019)

CRISPR/Cas-based customization of pooled CRISPR libraries
por: Kweon, Jiyeon, et al.
Publicado: (2018)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

Special focus CRISPR-Cas
por: Marchfelder, Anita
Publicado: (2013)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_copt9h5amajmmfmhiqhnq4msn5